Tagged: Medical Research
The Truth About Vaccines Documentary is available to view for FREE
The Truth About Vaccines is a 9-episode documentary series featuring some of the most renowned vaccine and health experts in the world. It took Ty and Charlene Bollinger many years of research to prepare this Documentary.
The Truth About Vaccines is brought to you by TTAV Global, LLC.
Parents should be informed about both the benefits and the risks associated with vaccines — without pressure, propaganda, or agenda.
So they brought together more than 60 of the world’s foremost health experts to investigate both sides of this contentious debate to give you the science, the history, and the untold story… the REAL information you need to make an informed decision on how to best protect your child.
Episode 1 — The History of Vaccines, Smallpox, Vaccine Safety & the Current CDC Schedule (Airs on April 22nd at 9pm Eastern)
Episode 2 — What’s in a Vaccine? Are Vaccines Effective? … and … What About Polio? (Airs on April 23rd at 9pm Eastern)
Episode 3 — An Analysis of the MMR & DTaP Vaccines & Vaccinating for the Greater Good (Airs on April 24th at 9pm Eastern)
Episode 4 — Examining Influenza, the HIB and Pneumococcal Vaccines & Herd Immunity (Airs on April 25th at 9pm Eastern)
Episode 5 — Considering the HPV and Hepatitis B Vaccines, SIDS & Shaken Baby Syndrome (Airs on April 26th at 9pm Eastern)
Episode 6 — A Closer Look at the CDC, Chicken-Pox and Rotavirus Vaccines & Retroviruses (Airs on April 27th at 9pm Eastern)
Episode 7 — Natural Immunization, Homeoprophylaxis & Fundamental Freedom of Choice (Airs on April 28th at 9pm Eastern)
Episode 8 (bonus) — Censorship & Suppression (Airs on April 29th at 9pm Eastern)
Episode 9 (bonus) — WHO’s Not Telling the Truth? (Airs on April 30th at 9pm Eastern)
You can either copy and paste the following URL into a web browser windows or just click on the link to start viewing the Documentary : https://go.thetruthaboutvaccines.com/?ref=cf34163a-6841-4ae0-ab68-ab4d3867c449
Disclaimer: The information in this post is presented for educational purposes only and is not intended to diagnose or prescribe for any medical or psychological condition, nor to prevent, treat, mitigate or cure such conditions. The information contained herein is not intended to replace a one-on-one relationship with a doctor or qualified healthcare professional. Therefore, this information is not intended as medical advice, but rather a sharing of knowledge and information based on research and experience. The Truth About Vaccines encourages you to make your own health care decisions based on your judgment and research in partnership with a qualified healthcare professional.
New Research Study done at the University of Ottawa suggests that Coronavirus was spread to Humans by Dogs and not by Bats.
A newly published research study by Xuhua Xai, a full Professor and researcher at the University of Ottawa (in Canada), points to Dogs and not Bats as causing the spread of Coronavirus COVID-19 to Humans.
The following is the Abstract from the study published in the Journal of Molecular Biology and Evolution:
Abstract
Click on this link to visit the Journal of Molecular Biology and Evolution website to download a PDF of the Research Study titled:”Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense”.
Click on this link to visit the Journal of Molecular Biology and Evolution website.
Click on this link to visit the University of Ottawa page for Xuhua Xai.
Posted by Vincent Banial with permission from the Journal of Molecular Biology and Evolution and the author Xuhua Xai.
Using Brewer’s Yeast to produce Marijuana’s main ingredients : mind-altering THC and non-psychoactive CBD
You no longer need to grow a Marijuana plant to extract THC and CBD. You can get both by using Brewer’s Yeast and Sugar. You also get purer products. For example you can make CBD without the worry of it also containing THC.
This is revolutionary. It could eliminate huge Marijuana plant grow operations. It could also produce Cannabinoids which cannot be obtained from Marijuana plants. The consistency and purity of the produced product can be regulated to be uniform from batch to batch. This new process offers great potential in finding, via Medical Research Studies, new medical benefits of THC, CBD and other Cannabinoids.
Cristina Sánchez has been studying Cannabis for fifteen years at Complutense University in Madrid Spain. She has discovered that THC from Cannabis can kill Cancer cells.
Dr Christina Sanchez explains how cannabis kills cancer cell from Life With Cannabis on Vimeo.
Being able to produce Medical Cannabis products like THC in a pure form using Brewer’s Yeast opens up a lot of potential in the Medical field as you can maintain purity and quality in each batch produced. For example, there have been documented cases of patients who have seizures and are helped by CBD. You also eliminate the potential use of Pesticides in Plant Grow Operations.
Click on this link to visit the website of the journal Nature and read the abstract of the February 27 2019 published research article titled: “Complete biosynthesis of cannabinoids and their unnatural analogues in yeast“.
Click on this link to visit the ScienceDaily website to read the research report titled: “Benefits of medical marijuana for treatment of epilepsy examined“
Click on this link to visit the Bloomberg website to read their page about Demetrix Inc.
The information provided about cannabis is for informational purposes only. Please consult your physician before making any medical decisions.
Posted by Vincent Banial
How effective is Chemotherapy as a treatment for Cancer?
Posted by Vincent Banial
Chemotherapy can be an effective treatment for Hodgkin’s disease (HD) – a type of lymphoma, which is a blood cancer. Chemotherapy can also be an effective form of treatment for Testicular Cancer.
What about other Cancers?
The following is taken from the abstract of that research Study :
“The overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in Australia and 2.1% in the USA.”
The conclusion as found in the abstract was:
“it is clear that cytotoxic chemotherapy only makes a minor contribution to cancer survival. To justify the continued funding and availability of drugs used in cytotoxic chemotherapy, a rigorous evaluation of the cost-effectiveness and impact on quality of life is urgently required.”.
Found a link using a web search. The link is below ( you have to copy and paste the URL if you wish to visit their site – as you would from a web search):
http://healingpathwaysmedical.com/docs/chemotherapy-5-year-survival-stats.pdf
Basically that is supposed to be a PDF of the results from that study published on Dec 2004 in Clinical Oncology. It lists over twenty different Cancers and the percentage increases in 5 year survival rates for those patients who received Chemotherapy treatment for said Cancer.
Clinical Oncology had also published another research study in November 2004. You can view an abstract at nature.com by clicking on this line.
The following was the conclusion of the Nov 2004 published in Nov 2004:
“Adjuvant chemotherapy after potentially curative surgery can improve 5-year survival by 4% in patients with early-stage non-small-cell lung cancer (NSCLC, stages IB–IIIA).”.
So after surgery, Chemotherapy may increase the 5 year survival rate in about 4% of the patients. Yes, only 4%.
Using the above quoted studies and being overly generous, in my opinion it may seem that Chemotherapy does not increase the 5 year Survival Rate for about 85% of patients with many forms of Cancer. The exception is that yes it may be a form of effective treatment for Hodgkin’s Disease and for the treatment of Testicular Cancer.
With some Cancers the study chart (see the link to the PDF above) shows Chemotherapy to have zero effect on 5 years Survival Rate.
That leaves the question: Why is Chemotherapy being given to Cancer patients?
Disclaimer: The above is posted for information purposes only. I am not giving Medical Advice. If you have a medical issue please consult with your Licensed Medical Doctor, Specialist or other Medical Professional.
How Cannabis kills Cancer Cells by Dr, Christina Sanchez
How Cannabis kills Cancer Cells
by Dr, Christina Sanchez
Video is courtesy of the Lincoln Horsley YouTube channel
“Cannabis has been shown to kill cancer cells in the laboratory ” posted by the National Cancer Institue at cancer.gov
Something which has apparently been known in Cancer Research circles, has been formally announced to the public.
“Cannabis has been shown to kill cancer cells in the laboratory” posted by the National Cancer Institue at cancer.gov
Photo courtesy of the United States Fish and Wildlife Service
The info below is from the website of the National Cancer Institute (https://www.cancer.gov)
Cannabis and Cannabinoids (PDQ®)–Patient Version
Sections
- Overview
- Questions and Answers About Cannabis
- Current Clinical Trials
- About This PDQ Summary
- General CAM Information
- Evaluation of CAM Therapies
- Questions to Ask Your Health Care Provider About CAM
- To Learn More About CAM
- View All Sections
Overview
- Cannabis , also known as marijuana, is a plant grown in many parts of the world which produces a resin containing compounds called cannabinoids. Some cannabinoids are psychoactive (acting on the brain and changing mood or consciousness) (see Question 1).
- The use of Cannabis for medicinal purposes dates back to ancient times (see Question 3).
- By federal law, the possession of Cannabis is illegal in the United States outside of approved research settings. However, a growing number of states, territories, and the District of Columbia have enacted laws to legalize medical marijuana (see Question 1).
- In the United States, Cannabis is a controlled substance requiring special licensing for its use (see Question 1 and Question 3).
- Cannabinoids are active chemicals in Cannabis that cause drug -like effects throughout the body, including the central nervous system and the immune system (see Question 2).
- The main active cannabinoid in Cannabis is delta-9-THC. Another active cannabinoid is cannabidiol (CBD), which may relieve pain, lower inflammation, and decrease anxiety without causing the “high” of delta-9-THC (see Question 2).
- Cannabinoids can be taken by mouth, inhaled, or sprayed under the tongue (see Question 5).
- Cannabis and cannabinoids have been studied in the laboratory and the clinic for relief of pain, nausea and vomiting, anxiety, and loss of appetite (see Question 6 and Question 7).
- Cannabis and cannabinoids may have benefits in treating the symptoms of cancer or the side effects of cancer therapies. There is growing interest in treating children for symptoms such as nausea with Cannabis and cannabinoids, although studies are limited (see Question 7).
- Two cannabinoids (dronabinol and nabilone) are drugs approved by the U.S. Food and Drug Administration (FDA) for the prevention or treatment of chemotherapy -related nausea and vomiting (see Question 7 and Question 10).
- Cannabis has been shown to kill cancer cells in the laboratory (see Question 6).
- At this time, there is not enough evidence to recommend that patients inhale or ingest Cannabis as a treatment for cancer-related symptoms or side effects of cancer therapy (see Question 7).
- Cannabis is not approved by the FDA for use as a cancer treatment (see Question 9).
******* end of post from cancer.gov *******
The following are additional links with info related to Cannabis and THC being able to kill Cancer Cells:
Antineoplastic Activity of Cannabinoids
http://www.ukcia.org/research/Antineo…
Cannabinoid Receptor Ligands Mediate Growth Inhibition & Cell Death In Mantle Cell Lymphoma
http://onlinelibrary.wiley.com/doi/10…
Δ9-Tetrahydrocannabinol Induces Apoptosis in Human Prostate PC-3 Cells via a Receptor-Independent Mechanism
http://onlinelibrary.wiley.com/doi/10…
Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma
http://jpet.aspetjournals.org/content…
Cannabinoid Receptors As Novel Targets for the Treatment of Melanoma
http://bbml.ucm.es/cannabis/archivos/…
DEA Eliminates 48-Year-Old Monopoly on Research-Grade Marijuana, Clearing Pathway for FDA Approval and Rescheduling
Photo of Cannabis plants courtesy of A7nubis and commons.wikimedia.org
Note from Vince: This is am extremely important change as the Cannabis grown by NIDA is an uncommon variety and apparently low in THC. The FDA could approve a Medical Study of the use of high THC Cannabis in the treatment of Cancer, but NIDA always had the final word. If they approved a medical study (their usual common response was “No”) the study had to use the NIDA supplied Cannabis variety.
WASHINGTON, D.C. — Today, the Drug Enforcement Administration (DEA) announced their intention to grant licenses to additional marijuana growers for research, thereby ending the DEA-imposed 48-year monopoly on federally legal marijuana. Since 1968, the University of Mississippi, under contract to the National Institute on Drug Abuse (NIDA), has maintained the only facility in the United States with federal permission to grow marijuana for research.
“It’s a complete and total end of the NIDA monopoly! There has been no production monopoly on any other Schedule I substance, like MDMA or LSD—only the cannabis plant. Licensing non-government cannabis producers, and thereby creating a path to FDA approval, will finally facilitate the removal of marijuana from Schedule I, and ultimately allow patients to receive insurance coverage for medical marijuana,” said Rick Doblin, Ph.D., Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS).
MAPS has been working to eliminate this cannabis research blockade since 1999. NIDA’s marijuana is eligible for research, but cannot be sold as a prescription medicine, making it unacceptable to the Food and Drug Administration (FDA) for use in future Phase 3 studies. Ending the monopoly finally allows for a pathway to FDA approval for marijuana, which would thereby trigger rescheduling.
In 2001, MAPS partnered with University of Massachusetts-Amherst Professor Lyle Craker, Ph.D., to apply for a DEA license and end the monopoly. In 2007, after years of bureaucratic delays and lengthy legal hearings, a DEA Administrative Law Judge (ALJ) recommended that it would be in the public’s interest to grant Craker the license. In 2009, after almost two more years of delays and less than a week before the inauguration of President Obama, former DEA Administrator Michelle Leonhart rejected the ALJ recommendation. In 2011, Craker sued the DEA in the U.S. First Circuit Court of Appeals. In its 2013 decision, the Court uncritically accepted the DEA’s arguments that NIDA’s monopoly provided “an adequate supply produced under adequately competitive conditions.”
Since the 2013 decision, Craker’s argument that NIDA does not have an adequate supply has become significantly more apparent. NIDA has been unable to provide the strains requested for MAPS’ long-delayed Phase 2 clinical trial of smoked marijuana to treat symptoms of posttraumatic stress disorder (PTSD) in 76 U.S. veterans. As a result, the study is proceeding with lower potency marijuana than what MAPS researchers requested.
The DEA has previously claimed that U.S. international treaty obligations under the United Nations Single Convention on Narcotic Drugs (Single Convention) require a federal monopoly, but in April 2016, the State Department released a statement clarifying that the Single Convention does not in fact limit the number of U.S. marijuana producers.
Furthermore, the DEA’s 2009 rejection of the ALJ recommendation to license Craker relied heavily on a U.S. Department of Health and Human Services (HHS) protocol review process, which was eliminated in 2015.
MAPS’ upcoming Phase 2 clinical trial of marijuana for PTSD in veterans is in collaboration with investigators in Phoenix, Arizona, and at Johns Hopkins University, the University of Colorado, and the University of Pennsylvania. The study is funded by a $2.15 million grant to MAPS from the State of Colorado. The study has received full regulatory approval, and will be the first randomized controlled trial of whole plant marijuana as a treatment for PTSD.
Founded in 1986, MAPS is a non-profit research and educational organization working to evaluate the safety and efficacy of botanical marijuana as a potential prescription medicine for specific medical uses approved by the FDA.
MORE INFORMATION
- Official Statement from DEA
- 2007 DEA Administrative Law Judge Findings
- 2013 First Circuit Court Decision
- 2015 HHS Statement Ending PHS Protocol Review
- Legal analysis to be submitted in support of Craker’s new application
Additional information can be found at maps.org/research/mmj/dea-license.
CONTACT:
Rick Doblin, Ph.D., MAPS Executive Director
rick@maps.org
617-276-7806
Natalie Ginsberg, MAPS Policy & Advocacy Manager
natalie@maps.org
917-520-5531
The above Press Release is courtesy of the Multidisciplinary Association for Psychedelic Studies (MAPS) whose Mission Sates :
Mission
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
“Making Peace with Cannabis” by Zach Walsh, PhD, Assistant Professor in the UBC Department of Psychology
This TEDx Talk is titled “Making Peace with Cannabis“. It features Zach Walsh, PhD, who is an Assistant Professor in the UBC Department of Psychology and Co-Director for the Centre for the Advancement of Psychological Science and Law. He is also involved in a current study at UBC which is investigating treating PTSD using Medical Cannabis.
Video is courtesy of the TEDx Talks YouTube channel
Black Pepper Oil inhibited Cancer Cells proliferation by 3.5-86.8%.
Posted by Vincent Banial
The Medical Research Study was conducted by Bioactive Natural Products and Phytoceuticals, Department of Horticulture and National Food Safety and Toxicology Center, Michigan State University, East Lansing, Michigan 48824, USA. The results were authored by Liu Y1, Yadev VR, Aggarwal BB, Nair MG.
Study “results suggest that black pepper and its constituents like hot pepper, exhibit anti-inflammatory, antioxidant and anticancer activities“.
“The extracts of black pepper at 200 microg/mL and its compounds at 25 microg/mL inhibited LPO by 45-85%, COX enzymes by 31-80% and cancer cells proliferation by 3.5-86.8%.“
“Abstract“
“Black pepper (Piper nigrum) and hot pepper (Capsicum spp.) are widely used in traditional medicines. Although hot Capsicum spp. extracts and its active principles, capsaicinoids, have been linked with anticancer and anti-inflammatory activities, whether black pepper and its active principle exhibit similar activities is not known. In this study, we have evaluated the antioxidant, anti-inflammatory and anticancer activities of extracts and compounds from black pepper by using proinflammatory transcription factor NF-kappaB, COX-1 and -2 enzymes, human tumor cell proliferation and lipid peroxidation (LPO). The capsaicinoids, the alkylamides, isolated from the hot pepper Scotch Bonnet were also used to compare the bioactivities of alkylamides and piperine from black pepper. All compounds derived from black pepper suppressed TNF-induced NF-kappaB activation, but alkyl amides, compound 4 from black pepper and 5 from hot pepper, were most effective. The human cancer cell proliferation inhibitory activities of piperine and alklyl amides in Capsicum and black pepper were dose dependant. The inhibitory concentrations 50% (IC50) of the alklylamides were in the range 13-200 microg/mL. The extracts of black pepper at 200 microg/mL and its compounds at 25 microg/mL inhibited LPO by 45-85%, COX enzymes by 31-80% and cancer cells proliferation by 3.5-86.8%. Overall, these results suggest that black pepper and its constituents like hot pepper, exhibit anti-inflammatory, antioxidant and anticancer activities.”.
Click on this line to visit the US National Library of Medicine National Institutes of Health PubMed site to read about this research titled “Inhibitory effects of black pepper (Piper nigrum) extracts and compounds on human tumor cell proliferation, cyclooxygenase enzymes, lipid peroxidation and nuclear transcription factor-kappa-B.
New Medical Study: “Creating beauty: Creativity compensates for low physical attractiveness when individuals assess the attractiveness of social and romantic partners” by Christopher D. Watkins
If you are a lucky male who was born incredibly handsome, you may want to skip this discussion of a new Scientific Study. On the other hand, if you are an average or below average looking male, this new Study titled: “Creating beauty: Creativity compensates for low physical attractiveness when individuals assess the attractiveness of social and romantic partners” by
I run this blog and shoot photographs of events such as shows and concerts. I do it for the fun of it. Today I learned that there are other benefits to being “creative” and displaying your creativity. My creativity will compensate for my “not being” a total male hunk and Eye Candy in a woman’s eyes. That’s not to say that I’m ugly, just average looking. Ask any guy if they would prefer a beautiful girlfriend or one which looks just average. Surprise, the same goes for women. Humans prefer beauty in their partners. It is instinctive and meant to help continue with the survival of the human species.
This newly published Research Study conducted by Christopher Watkins of Abertay University in Scotland helps to explain some of the extremely gorgeous women that I have dated in my life. The downside of dating a really great looking woman is that any other guys in the same room will be doing body scans of your girlfriend.
So how is that a physically gorgeous female super model would even go out with an average looking guy like me?
Unfortunately, this does not apply to women. Displays of creativity by an average looking women, will not enhance her appeal to the eyes of a male. Us males are rather fixated on physical beauty. Your average looking female can have tons of “inner beauty” and in the end that is far more important. But males generally look at the outer packaging.
Enough of Vince’s banter, I know that the readers here can’t wait to view this new Research Study, which is below. Please note that I am posting this new research with permission, but that does not mean that
Abstract
Although creativity is attractive in a potential mate, it is unclear (i) whether the effects of creativity on attractiveness generalize to other social contexts and (ii) whether creativity has equivalent effects on men’s and women’s attractiveness. As social knowledge of creativity may either enhance or ‘offset’ the appeal of social partners who differ in physical attractiveness, three repeated measures experiments were conducted to directly address these issues. Here, participants rated a series of face–text pairs for attractiveness on trials that differed in one of four combinations of facial attractiveness (attractive and less attractive) and creativity (creative and less creative), rating story-tellers in two experiments (short interpretations of an identical painting) and creative ideas in a further experiment (alternative uses for an everyday object). Regardless of the sex of the judge, creativity and facial attractiveness had independent effects on men’s overall attractiveness (initial experiment) and, in further experiments, more substantial effects on the attractiveness of men with less attractive faces than men with attractive faces (when using a different measure of creativity) and specific effects on the attractiveness of individuals with less attractive faces (when using different face stimuli). Collectively, across three experiments, these findings suggest that creativity may compensate for putative cues to lower biological ‘quality’ and that the benefits of creativity to social groups more generally enhance attraction to creative men (in two experiments) and creative men and women (one experiment). More broadly, the data suggest that species can integrate knowledge of cognitive intelligence with visual cues to biological ‘quality’ to facilitate mate and/or ally choice.
Researchers found that those who took acetaminophen showed a reduction in empathy.
A new Research Study out of The Ohio State University found that those who took acetaminophen showed a reduction in empathy. They weren’t as concerned about another person’s person’s hurt feelings. The Study was published on May 05 2016 in the journal “Social Congitive and Affective Neuroscience“, which is one of the Oxford Journals.
Video is courtesy of the Fox Business YouTube channel
Acetaminophen is the main ingredient in the over the counter pain relief medication called Tylenol.
The authors of the study were:
and Jennifer Crocker
Click on this line to visit the Oxford Journals site to view the Study Abstract “
From Painkiller to Empathy Killer: Acetaminophen (Paracetamol) Reduces Empathy for Pain
Posted by: Vincent Banial
http://www.uniquelytoronto.com
Disclaimer: Any Trademarks mentioned in this post are owned by the respective Trademark owner. There could be unintentional errors or omissions in this post. Always refer to the official sites to confirm details and any ongoing changes or updates. This post is subject to change without notice.
Northwestern researchers have discovered that when the human egg is activated by a sperm enzyme, an explosion of zinc sparks erupt
Northwestern University researchers have discovered that when the human egg is activated by a sperm enzyme, an explosion of zinc sparks erupt
If the videos do not start automatically, then click on the two links below. They are from the study published in Scientific Reports
http://www.nature.com/article-assets/npg/srep/2016/160426/srep24737/extref/srep24737-s1.avi
http://www.nature.com/article-assets/npg/srep/2016/160426/srep24737/extref/srep24737-s2.avi
Video is courtesy of GeoBeats News YouTube channel
Abstract
Egg activation refers to events required for transition of a gamete into an embryo, including establishment of the polyspermy block, completion of meiosis, entry into mitosis, selective recruitment and degradation of maternal mRNA, and pronuclear development. Here we show that zinc fluxes accompany human egg activation. We monitored calcium and zinc dynamics in individual human eggs using selective fluorophores following activation with calcium-ionomycin, ionomycin, or hPLCζ cRNA microinjection. These egg activation methods, as expected, induced rises in intracellular calcium levels and also triggered the coordinated release of zinc into the extracellular space in a prominent “zinc spark.” The ability of the gamete to mount a zinc spark response was meiotic-stage dependent. Moreover, chelation of intracellular zinc alone was sufficient to induce cell cycle resumption and transition of a meiotic cell into a mitotic one. Together, these results demonstrate critical functions for zinc dynamics and establish the zinc spark as an extracellular marker of early human development.
Click on this line to visit the Scientific Reports website to read the complete study titled:
The zinc spark is an inorganic signature of human egg activation
Please note that there is download link at the above linked to Scientific Reports site, which allows you to download the full study report.
Title:
The zinc spark is an inorganic signature of human egg activation
Authors: Francesca E. Duncan, Emily L. Que, Nan Zhang, Eve C. Feinberg, Thomas V. O’Halloran et al.
Publication: Scientific Reports
Publisher: Nature Publishing Group
Date: Apr 26, 2016
Copyright © 2016, Rights Managed by Nature Publishing Group
Creative Commons
The article for which you have requested permission has been distributed under a Creative Commons CC-BY license (please see the article itself for the license version number). You may reuse this material without obtaining permission from Nature Publishing Group, providing that the author and the original source of publication are fully acknowledged, as per the terms of the license.
For license terms, please see http://creativecommons.org/
Posted by: Vincent Banial
http://www.uniquelytoronto.com
Disclaimer: Any Trademarks mentioned in this post are owned by the respective Trademark owner.
If the Cancerous Tumor can be reached by thin optic fibers then this minimally invasive procedure could be an effective way to treat said Tumor
Getting any form of cancer can be life changing. The medical procedures used to eliminate the Cancer can also have life changing side effects.
Removing a Cancerous Prostate is one present way to deal with Colon Cancer.
There is a novel new procedure which has already been approved for use in Mexico. It may soon be approved for use in Europe.
The key part is that the procedure is minimally invasive. If the Cancerous Tumor can be reached by thin optic fibers then this procedure could be an effective way to treat said Tumor. The thin optic fiber is needed to direct the Laser light at the Tumor. “Laser light activation of an intravenous infusion of Tookad Soluble releases short-lived toxic oxygen and nitric oxide radicals that destroy the Cancer tumor’s blood vessels and thereby kill the tumorous cells”. The Tookad Soluble drug is eliminated from the body in less than 6 hours. Without the Laser Light activation the Tookad Soluble has no effect on other cells or organ. Ultra Sound is used to feed and direct the Optic Fibres into the patients body.
This new technology was developed by the Yeda Research and Development Company, of the Weizmann Institute in collaboration with Steba Biotech of Luxembourg. Steba Biotech received the license for Tookad Soluble from Yeda Research and Development Company.
Since this procedure can target Cancer Tumors where a Fibre Optic strand could reach the tumor, then the door may be open to treat many other forms of Cancer. More research and Clinical Studies are underway.
Posted by: Vincent Banial
http://www.uniquelytoronto.com
Disclaimer: Any Trademarks mentioned in this post are owned by the respective Trademark owner. There could be unintentional errors or omissions in this post. Always refer to the official sites to confirm details and any ongoing changes or updates. This post is subject to change without notice.
Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model
I used to post about Medical Research in the past. For example, our prior post about research done at Harvard regarding the association between Heart Disease and microbial Human Gut Bacteria had researchers from around the globe visiting this site. Hey life is not just about great looking Exotic Cars, great looking Women and great sounding Music. You should add Medical Research to “round out” that mix.
This post is about research being conducted in Australia, which shows great promise in the treatment of Alzheimers. Apparently some memory loss could be reversed, in mice so far, by using their protocol and Scanning UltraSound.
The study was conducted by : Gerhard Leinenga and Jürgen Götz. Corresponding author. E-mail: j.goetz@uq.edu.au
Their study was published in the peer reviewed journal: Science Translational Medicine 11 Mar 2015: Vol. 7, Issue 278
The article was titled: Research Article Alzheimer’s Disease
Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model.
The following is the Abstract (posted for Educational purposes). A link is provided further down to access the complete text and a downloadable PDF.
Abstract
Amyloid-β (Aβ) peptide has been implicated in the pathogenesis of Alzheimer’s disease (AD). We present a nonpharmacological approach for removing Aβ and restoring memory function in a mouse model of AD in which Aβ is deposited in the brain. We used repeated scanning ultrasound (SUS) treatments of the mouse brain to remove Aβ, without the need for any additional therapeutic agent such as anti-Aβ antibody. Spinning disk confocal microscopy and high-resolution three-dimensional reconstruction revealed extensive internalization of Aβ into the lysosomes of activated microglia in mouse brains subjected to SUS, with no concomitant increase observed in the number of microglia. Plaque burden was reduced in SUS-treated AD mice compared to sham-treated animals, and cleared plaques were observed in 75% of SUS-treated mice. Treated AD mice also displayed improved performance on three memory tasks: the Y-maze, the novel object recognition test, and the active place avoidance task. Our findings suggest that repeated SUS is useful for removing Aβ in the mouse brain without causing overt damage, and should be explored further as a noninvasive method with therapeutic potential in AD.
Click on this line to view the complete text regarding the published results of this study.
Click on this line to visit the Clem Jones Centre for Ageing Dementia Research (CJCADR)
Posted by: Vincent Banial
http://www.uniquelytoronto.com
Disclaimer: Any Trademarks mentioned in this post are owned by the respective Trademark owner. There could be unintentional errors or omissions in this post. Always refer to the official sites to confirm details and any ongoing changes or updates. This post is subject to change without notice. The Study Abstract has been included in this post for Educational Purposes and so is covered by the Fair Use component of Copyright. Uniquely Toronto makes no claims regarding the copyright or other rights to the published material. Also complete links have been included to the Science Translational Medicine site.
Uniquely Toronto 